1. Ophthalmic composition containing a polyaphron dispersion. 2. Ophthalmic composition according to claim 1 in the form of a liquid. 3. Ophthalmic composition according to claim 1 in the form of eye drops. 4. Ophthalmic composition according to claim 1, containing a pharmaceutically active agent. The ophthalmic composition according to claim 4, wherein the pharmaceutically active agent is selected from the group consisting of an antihistamine, beta blocker, corticosteroid, prostaglandin, non-steroidal anti-inflammatory drugs (NSAIDs), immunomodulator, anesthetic, antibiotic, carbonic anhydrase inhibitor, vasoconstrictor drug and mixtures or more of them. 6. The ophthalmic composition according to claim 4, wherein the pharmaceutically active agent comprises cyclosporin. Ophthalmic composition according to claim 1, where this composition has an osmolality of 200 to 600 mosm / kg. An ophthalmic composition according to claim 1, comprising a tonicity-controlling agent, preferably selected from sugar, sugar alcohol, glycol, urea, and mixtures of two or more of them. The ophthalmic composition according to claim 1, containing omega-3 fatty acid. The ophthalmic composition according to claim 1, wherein the composition has a pH from 3.5 to 9, preferably from 5 to 8, more preferably from 6 to 7.5.11. Ophthalmic composition according to claim 1, containing a gelling agent. The ophthalmic composition according to claim 1, having a viscosity of 1 to 50 Pa с • s at a shear rate of 1 s. The ophthalmic composition according to claim 1, wherein the surfactant is selected from one or more nonionic surfactants (a), cationic surfactants (a), anionic surfactants (a), zwitterionic surfaces1. Офтальмическая композиция, содержащая полиафроновую дисперсию.2. Офтальмическая композиция по п. 1 в виде жидкости.3. Офтальмическая композиция по п. 1 в виде глазных капель.4. Офтальмическая композиция по п. 1, содержащая фармацевтически активный агент.5. Офтальмическая композиция по п. 4, в котор
